About Mitogene Technologies Private Limited
Data last updated:
Mitogene Technologies Private Limited is a private limited company based in Chengalpattu, Tamil Nadu, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 30 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U85110TN2020PTC139109. Its GSTIN is 33AANCM9784H1ZT (Tamil Nadu).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹50,000. It is led by directors Durai Latha and Ashok Suyambukesan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 325 A Avigna Celeste Kunnavakkam Bo Echankaranai, Chengalpattu, Tamil Nadu, India – 603002.
As per the financials filed for FY 2025, the company reported a revenue of ₹43.61 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹16,043 (net margin -0.4%) and EBITDA of -₹16,043 (EBITDA margin -0.4%).
The company is associated with 1 brand: Mitogene.
For more details, the company can be reached via its website mitogene.in.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address325 A Avigna Celeste Kunnavakkam Bo Echankaranai, Chengalpattu, Tamil Nadu, India – 603002
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Mitogene Technologies Private Limited
The main business activity of Mitogene Technologies is professional, scientific and technical. In detail, this covers scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Mitogene Technologies Private Limited FY 2025 filings available
Mitogene Technologies Private Limited reported revenue of ₹43.61 Lakh (up 238% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Mitogene Technologies Private Limited
Revenue rose 238% in the latest year. EBITDA rose 97% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Mitogene Technologies Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹16,043 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹16,043 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Mitogene Technologies Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -0.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Mitogene Technologies are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Mitogene Technologies Private Limited
Mitogene Technologies Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Diagnostic Bazar E-Solution Private Limited | ₹44.07 Lakh (FY 2024) | •••• | •••• | -22.0% | •••• | Nangloi, Delhi, India |
| Master Scan & Labs Private Limited | ₹44.01 Lakh (FY 2024) | •••• | •••• | 3.0% | •••• | Kolathur, Tamil Nadu, India |
| Brindaban Medicare Pvt Ltd | ₹43.94 Lakh (FY 2024) | •••• | •••• | -18.0% | •••• | Jaipur, Rajasthan, India |
| Mediiaxon Private Limited | ₹43.83 Lakh (FY 2025) | •••• | •••• | 59.0% | •••• | Thane, Maharashtra, India |
| Sequence Referral Laboratories Private Limited | ₹43.67 Lakh (FY 2024) | •••• | •••• | -42.0% | •••• | New Delhi, Delhi, India |
| Mitogene Technologies Private Limited this company | ₹43.61 Lakh (FY 2025) | •••• | •••• | 238.0% | •••• | Chengalpattu, Tamil Nadu, India |
| Weeclu Solutions Private Limited | ₹43.6 Lakh (FY 2020) | •••• | •••• | 222.0% | •••• | Ganjam, Orissa, India |
| Aurelia Diagnostic Private Limited | ₹43.58 Lakh (FY 2025) | •••• | •••• | 280.0% | •••• | Kolkata, West Bengal, India |
| Sreechem Analytical Services Private Limited | ₹43.56 Lakh (FY 2023) | •••• | •••• | -8.0% | •••• | Rangareddy, Telangana, India |
| Crystal Diagnostic and Healthcare Private Limited | ₹43.53 Lakh (FY 2025) | •••• | •••• | -11.0% | •••• | Nagpur, Maharashtra, India |
| Magadh Diagnostic & Health Care Private Limited | ₹43.47 Lakh (FY 2023) | •••• | •••• | 9.0% | •••• | Patna, Bihar, India |
Peers are the five companies nearest above and the five nearest below Mitogene Technologies by revenue in the Healthcare industry (Diagnostics and Pathology Labs), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Mitogene Technologies Private Limited
Mitogene Technologies has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Durai Latha Also directs: Adjuvenz Technologies Private Limited | Director | 30 Oct 2020 | 5 Years 11 Months | Current |
| Ashok Suyambukesan Also directs: Adjuvenz Technologies Private Limited | Director | 30 Oct 2020 | 5 Years 11 Months | Current |
Ownership and Shareholding of Mitogene Technologies Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Mitogene Technologies Private Limited
Mitogene Technologies Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Associated Brands with Mitogene Technologies Private Limited
Mitogene Technologies operates one associated brand: Mitogene. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides pharmaceutical exports, medical devices, and patient services worldwide. | mitogene.in |
Employees and EPFO Compliance at Mitogene Technologies Private Limited
Mitogene Technologies Private Limited has a workforce of 0 employees as of Apr 09, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Mitogene Technologies Private Limited
Mitogene Technologies Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Ashok Suyambukesan was appointed as Director on 30 Oct 2020.
Credit Ratings, Litigation & Regulatory Alerts for Mitogene Technologies Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Mitogene Technologies Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Mitogene Technologies Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Mitogene Technologies Private Limited
Mitogene Technologies has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AANCM9784H1ZT | Tamil Nadu | Active | 24 Nov 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Mitogene Technologies Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mitogene Technologies Private Limited
Mitogene Technologies is an active private limited company based in Chengalpattu, Tamil Nadu, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 30 October 2020 (6+ years old) and is registered under CIN U85110TN2020PTC139109.
Mitogene Technologies reported revenue of ₹43.61 Lakh for FY 2025 (up 238% YoY).
Mitogene Technologies has 2 current directors:
- Durai Latha - Director
- Ashok Suyambukesan - Director
Mitogene Technologies reported a net loss of ₹16,043 (net margin -0.4%) and EBITDA of -₹16,043 (EBITDA margin -0.4%) for FY 2025, as per its filed financial statements.
The GSTIN of Mitogene Technologies is 33AANCM9784H1ZT, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Mitogene Technologies is U85110TN2020PTC139109. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mitogene Technologies was incorporated on 30 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Mitogene Technologies by revenue are Diagnostic Bazar E-Solution Private Limited, Master Scan & Labs Private Limited, Brindaban Medicare Pvt Ltd, Mediiaxon Private Limited, Sequence Referral Laboratories Private Limited and 5 more, all in the Healthcare industry (Diagnostics and Pathology Labs).
Ashok Suyambukesan was appointed as Director on 30 Oct 2020. Durai Latha was appointed as Director on 30 Oct 2020.
Mitogene Technologies can be reached through the website mitogene.in. Its registered office is in Chengalpattu, Tamil Nadu, India.
The registered office of Mitogene Technologies is at 325 A Avigna Celeste Kunnavakkam Bo Echankaranai, Chengalpattu, Tamil Nadu, India – 603002.